BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37066362)

  • 41. m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.
    Gao M; Qi Z; Feng W; Huang H; Xu Z; Dong Z; Xu M; Han J; Kloeber JA; Huang J; Lou Z; Liu S
    J Biol Chem; 2022 Feb; 298(2):101563. PubMed ID: 34998823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single-stranded DNA binding proteins influence APOBEC3A substrate preference.
    Brown AL; Collins CD; Thompson S; Coxon M; Mertz TM; Roberts SA
    Sci Rep; 2021 Oct; 11(1):21008. PubMed ID: 34697369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers.
    Argyris PP; Wilkinson PE; Jarvis MC; Magliocca KR; Patel MR; Vogel RI; Gopalakrishnan R; Koutlas IG; Harris RS
    Mod Pathol; 2021 Feb; 34(2):280-290. PubMed ID: 32632179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
    Nik-Zainal S; Wedge DC; Alexandrov LB; Petljak M; Butler AP; Bolli N; Davies HR; Knappskog S; Martin S; Papaemmanuil E; Ramakrishna M; Shlien A; Simonic I; Xue Y; Tyler-Smith C; Campbell PJ; Stratton MR
    Nat Genet; 2014 May; 46(5):487-91. PubMed ID: 24728294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types.
    Chen Z; Wen W; Bao J; Kuhs KL; Cai Q; Long J; Shu XO; Zheng W; Guo X
    BMC Med Genomics; 2019 Sep; 12(1):131. PubMed ID: 31533728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes.
    Lada AG; Kliver SF; Dhar A; Polev DE; Masharsky AE; Rogozin IB; Pavlov YI
    PLoS Genet; 2015 May; 11(5):e1005217. PubMed ID: 25941824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
    Kim SH; Ahn S; Suh KJ; Kim YJ; Park SY; Kang E; Kim EK; Kim IA; Chae S; Choi M; Kim JH
    Breast Cancer Res Treat; 2020 Oct; 183(3):697-704. PubMed ID: 32715441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing.
    Sakhtemani R; Senevirathne V; Stewart J; Perera MLW; Pique-Regi R; Lawrence MS; Bhagwat AS
    J Biol Chem; 2019 Oct; 294(41):15037-15051. PubMed ID: 31431505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
    Kim YS; Sun S; Yoon JS; Ko YH; Won HS; Kim JS
    PLoS One; 2020; 15(3):e0230261. PubMed ID: 32176735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
    Udquim KI; Zettelmeyer C; Banday AR; Lin SH; Prokunina-Olsson L
    Carcinogenesis; 2020 Aug; 41(8):1030-1037. PubMed ID: 31930332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells.
    Shinohara M; Io K; Shindo K; Matsui M; Sakamoto T; Tada K; Kobayashi M; Kadowaki N; Takaori-Kondo A
    Sci Rep; 2012; 2():806. PubMed ID: 23150777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses.
    DiMarco AV; Qin X; McKinney BJ; Garcia NMG; Van Alsten SC; Mendes EA; Force J; Hanks BA; Troester MA; Owzar K; Xie J; Alvarez JV
    Cancer Immunol Res; 2022 Jan; 10(1):70-86. PubMed ID: 34795033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression.
    Yamazaki H; Shirakawa K; Matsumoto T; Kazuma Y; Matsui H; Horisawa Y; Stanford E; Sarca AD; Shirakawa R; Shindo K; Takaori-Kondo A
    PLoS One; 2020; 15(1):e0223463. PubMed ID: 31914134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression.
    Wang D; Li X; Li J; Lu Y; Zhao S; Tang X; Chen X; Li J; Zheng Y; Li S; Sun R; Yan M; Yu D; Cao G; Yang Y
    Gut; 2019 Oct; 68(10):1846-1857. PubMed ID: 31154396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
    Ito F; Fu Y; Kao SA; Yang H; Chen XS
    J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Within-Host Variations of Human Papillomavirus Reveal APOBEC Signature Mutagenesis in the Viral Genome.
    Hirose Y; Onuki M; Tenjimbayashi Y; Mori S; Ishii Y; Takeuchi T; Tasaka N; Satoh T; Morisada T; Iwata T; Miyamoto S; Matsumoto K; Sekizawa A; Kukimoto I
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of APOBEC3 mutagenesis in human cancer cells.
    Petljak M; Dananberg A; Chu K; Bergstrom EN; Striepen J; von Morgen P; Chen Y; Shah H; Sale JE; Alexandrov LB; Stratton MR; Maciejowski J
    Nature; 2022 Jul; 607(7920):799-807. PubMed ID: 35859169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. APOBEC3B is preferentially expressed at the G2/M phase of cell cycle.
    Hirabayashi S; Shirakawa K; Horisawa Y; Matsumoto T; Matsui H; Yamazaki H; Sarca AD; Kazuma Y; Nomura R; Konishi Y; Takeuchi S; Stanford E; Kawaji H; Murakawa Y; Takaori-Kondo A
    Biochem Biophys Res Commun; 2021 Mar; 546():178-184. PubMed ID: 33592502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perturbation of base excision repair sensitizes breast cancer cells to APOBEC3 deaminase-mediated mutations.
    Shen B; Chapman JH; Custance MF; Tricola GM; Jones CE; Furano AV
    Elife; 2020 Jan; 9():. PubMed ID: 31904337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.